Stock listing
Frankfurt:7JS Diagnostyka S.A. Aktie
German listing (Frankfurt) of Diagnostyka S.A. · home listing GPW:DIA
Follow Diagnostyka S.A. into a list and get an email when it puts out news.
Share price · FWB:7JS
€33.40 EUR -0.34 (-1.0%)
Close on Nov 20, 2026
- Day range
- €33.02 – €33.40 EURNov 20, 2026
- Market cap
- €1.13B EURAt the close on Nov 20, 2026 · price × 33.76M shares outstanding
- 52-week range
- €32.02 – €48.43 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €0 EURMedian day 0 shares · 57 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| GPW:DIA · Home | 151.00 PLN | -1.00 (-0.7%) | 46,433 | 148.80 | 152.80 | 148.00 | 152.00 | Close on Nov 20, 2026 |
| Frankfurt:7JS | €33.40 EUR | -0.34 (-1.0%) | — | €33.02 | €33.40 | €33.02 | €33.74 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:7JS · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €33.25 | -0.501 | -1.5% | €33.83 | €33.87 | €33.17 | 0 | |
| €33.75 | +0.475 | +1.4% | €33.81 | €33.81 | €33.62 | 0 | |
| €33.27 | +0.631 | +1.9% | €33.35 | €33.40 | €32.89 | 0 | |
| €32.64 | +0.085 | +0.3% | €32.74 | €32.74 | €32.02 | 0 | |
| €32.56 | -0.813 | -2.4% | €33.47 | €33.68 | €32.49 | 0 | |
| €33.37 | -0.178 | -0.5% | €33.56 | €34.13 | €33.05 | 0 | |
| €33.55 | +0.117 | +0.3% | €33.80 | €33.86 | €33.47 | 0 | |
| €33.43 | -0.144 | -0.4% | €33.92 | €34.18 | €33.23 | 0 | |
| €33.57 | -0.811 | -2.4% | €34.08 | €34.10 | €33.55 | 0 | |
| €34.38 | -0.571 | -1.6% | €34.84 | €34.87 | €34.28 | 0 | |
| €34.96 | -0.341 | -1.0% | €35.50 | €35.51 | €34.76 | 0 | |
| €35.30 | +0.327 | +0.9% | €35.55 | €35.62 | €35.27 | 0 | |
| €34.97 | -0.028 | -0.1% | €35.09 | €35.10 | €34.76 | 0 | |
| €35.00 | -0.115 | -0.3% | €35.10 | €35.18 | €34.93 | 0 | |
| €35.11 | -0.508 | -1.4% | €36.23 | €36.33 | €34.77 | 0 | |
| €35.62 | -0.032 | -0.1% | €35.89 | €35.94 | €35.49 | 0 | |
| €35.65 | +0.269 | +0.8% | €36.02 | €36.07 | €35.26 | 0 | |
| €35.38 | -0.099 | -0.3% | €36.05 | €36.08 | €35.34 | 0 | |
| €35.48 | -0.117 | -0.3% | €36.24 | €36.44 | €35.19 | 0 | |
| €35.60 | +0.128 | +0.4% | €35.97 | €36.09 | €35.34 | 0 | |
| €35.47 | +0.165 | +0.5% | €35.57 | €35.68 | €35.39 | 0 | |
| €35.31 | -0.297 | -0.8% | €35.75 | €35.76 | €35.30 | 0 | |
| €35.60 | -0.979 | -2.7% | €36.53 | €36.74 | €35.51 | 0 | |
| €36.58 | +0.708 | +2.0% | €36.66 | €36.66 | €35.41 | 0 | |
| €35.87 | +0.156 | +0.4% | €36.28 | €36.37 | €35.71 | 0 | |
| €35.72 | -0.243 | -0.7% | €36.02 | €36.05 | €35.67 | 0 | |
| €35.96 | -0.124 | -0.3% | €36.47 | €36.50 | €35.54 | 0 | |
| €36.09 | -0.113 | -0.3% | €36.12 | €36.15 | €35.61 | 0 | |
| €36.20 | -0.352 | -1.0% | €36.99 | €37.56 | €36.19 | 0 | |
| €36.55 | -0.129 | -0.4% | €37.13 | €37.22 | €36.54 | 0 | |
| €36.68 | -0.041 | -0.1% | €36.88 | €36.89 | €36.42 | 0 | |
| €36.72 | +0.185 | +0.5% | €37.37 | €37.39 | €36.72 | 0 | |
| €36.54 | -0.79 | -2.1% | €37.47 | €37.49 | €36.52 | 0 | |
| €37.33 | +0.202 | +0.5% | €38.01 | €38.05 | €37.15 | 0 | |
| €37.12 | +0.908 | +2.5% | €36.98 | €37.16 | €36.86 | 0 | |
| €36.22 | -0.781 | -2.1% | €37.36 | €37.48 | €36.12 | 0 | |
| €37.00 | +0.651 | +1.8% | €37.03 | €37.03 | €36.25 | 0 | |
| €36.35 | +0.278 | +0.8% | €36.41 | €36.67 | €36.18 | 0 | |
| €36.07 | -0.681 | -1.9% | €37.68 | €37.76 | €35.71 | 0 | |
| €36.75 | +0.723 | +2.0% | €36.62 | €36.75 | €36.48 | 0 | |
| €36.03 | -0.884 | -2.4% | €37.87 | €37.87 | €35.57 | 0 | |
| €36.91 | -0.554 | -1.5% | €38.00 | €38.26 | €36.85 | 0 | |
| €37.46 | -1.39 | -3.6% | €39.10 | €39.36 | €37.37 | 0 | |
| €38.85 | +0.106 | +0.3% | €39.04 | €39.04 | €38.67 | 0 | |
| €38.75 | +0.458 | +1.2% | €39.80 | €39.91 | €38.60 | 0 | |
| €38.29 | +0.092 | +0.2% | €38.27 | €38.45 | €37.99 | 0 | |
| €38.20 | -0.234 | -0.6% | €38.54 | €38.56 | €37.75 | 0 | |
| €38.43 | -0.377 | -1.0% | €38.88 | €38.96 | €38.19 | 0 | |
| €38.81 | +0.272 | +0.7% | €39.18 | €39.33 | €38.66 | 0 | |
| €38.54 | +0.164 | +0.4% | €38.55 | €38.57 | €37.95 | 0 | |
| €38.37 | -0.35 | -0.9% | €38.87 | €38.92 | €37.73 | 0 | |
| €38.72 | +0.265 | +0.7% | €39.11 | €39.23 | €38.40 | 0 | |
| €38.46 | +0.276 | +0.7% | €38.59 | €38.65 | €38.15 | 0 | |
| €38.18 | -0.036 | -0.1% | €38.27 | €38.28 | €37.97 | 0 | |
| €38.22 | +0.258 | +0.7% | €39.00 | €39.10 | €37.60 | 0 | |
| €37.96 | +0.58 | +1.6% | €38.00 | €38.00 | €37.82 | 0 | |
| €37.38 | -0.158 | -0.4% | €38.28 | €38.32 | €37.34 | 0 |
- Ticker
- Frankfurt:7JS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · May 28, 2026
Poland's Diagnostyka first-quarter profit rises on higher test prices
Latest deck · Sep 11, 2026
Q2 2026 Earnings Presentation
Earnings · 18 slides
Latest news
Poland's Diagnostyka first-quarter profit rises on higher test prices
May 28, 2026
Closed €41.19 (+10.3%) on May 29, 2026
DIA: Revenue and EBITDA surged, with stable margins and strong cash flow despite regulatory headwinds
Apr 21, 2026
Closed €36.25 (-1.7%) on Apr 22, 2026
Diagnostyka full-year profit rises on higher test volumes and prices
Apr 20, 2026
Closed €36.89 (-10.2%) on Apr 21, 2026
Diagnostyka Q3 profit soars on higher test volumes and prices
Nov 20, 2025
Closed €40.70 (-1.1%) on Nov 21, 2025
Diagnostyka S.A. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 3 in the last 12 months · 6 in all · newest May 28, 2026 · oldest 2025
- Decks
- 9 decks · latest Sep 11, 2026
Where Diagnostyka S.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| GPW:DIA · Home listing | GPW | Poland | PLN |
| gettex:7JS | gettex | Germany | EUR |
| Frankfurt:7JS · This page | Frankfurt | Germany | EUR |
| Munich:7JS | Munich | Germany | EUR |
| Dusseldorf:7JS | Dusseldorf | Germany | EUR |
| LS Exchange:A411E5 | LS Exchange | Germany | EUR |
Valuation
P/E 20.0× against a median of 43.1×: 3rd lowest of 11 Health care services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 5.82B PLN
- P/E
- 20.0×
- EV/sales
- 2.3×
- EV/EBITDA
- 9.6×
- Price/book
- 10.0×
- Gross margin
- 78.6%
- Operating margin
- 15.0%
- Net margin
- 9.9%
- Debt to equity
- 1.4×
- Beta
- No index for this market yet
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Diagnostyka S.A. · GPW:DIA | US$1.26B | US$1.43B | 20.0× | 2.3× | 9.6× | 10.0× | 9.9% | 1.4× | n/a |
| Ping An Healthcare and Technology Company Limited · HKEX:1833 | US$1.31B | US$233.6M | 23.0× | 0.3× | 9.0× | 0.9× | 6.9% | 0.0× | n/a |
| Spire Healthcare Group PLC · LSE:SPI | US$1.31B | US$2.98B | 60.9× | 1.4× | 9.4× | 1.4× | 1.0% | 1.8× | n/a |
| Sanbo Hospital Management Group Limited Class A · SZSE:301293 | US$1.30B | US$1.30B | 127× | 4.5× | n/a | 3.6× | 3.5% | 0.2× | n/a |
| Clariane SE · EURONEXT:CLARI | US$1.28B | US$8.88B | 731× | 1.5× | 8.0× | 0.3× | 0.0% | 2.3× | n/a |
| Metropolis Healthcare Ltd. · NSE:METROPOLIS | US$1.27B | US$1.26B | 52.4× | 6.6× | 26.0× | 7.2× | 12.6% | 0.2× | n/a |
| InnovAge Holding Corp. · NASDAQ:INNV | US$1.25B | US$1.13B | 139× | 1.1× | 31.3× | 4.9× | 0.9% | 0.2× | 0.72 |
| Netcare Limited · JSE:NTC | US$1.25B | US$1.91B | 12.5× | 1.3× | 6.8× | 2.0× | 6.6% | 1.3× | n/a |
| The Pennant Group, Inc. · NASDAQ:PNTG | US$1.22B | US$1.39B | 33.9× | 1.2× | 17.4× | 2.9× | 3.0% | 0.5× | 0.44 |
| CVS Group plc · LSE:CVSG | US$1.21B | US$1.61B | 5.3× | 0.2× | 2.3× | 3.2× | 2.4% | 1.1× | n/a |
| C.Q. Pharmaceutical Holding Co., Ltd. Class A · SZSE:000950 | US$1.21B | US$806.2M | 24.9× | 0.1× | n/a | 0.7× | 0.4% | 0.1× | n/a |
| Median of the others | US$1.26B | US$1.35B | 43.1× | 1.2× | 9.2× | 2.5× | 2.7% | 0.3× | 0.58 |
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- Price target
- 191.39 PLN · Analysts' mean
- EPS, year to Dec 2026
- 7.61 · 2 analysts
- Revenue, year to Dec 2026
- 2.75B · 5 analysts
Events
- Next results
- Nov 26, 2026 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Sep 10, 2026 · After close | −2.9% |
| Q1 2026 | May 29, 2026 | +4.6% |
| Q3 2025 | Nov 20, 2025 | −2.1% |
| Q2 2025 | Sep 18, 2025 | −1.8% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 18 slides | Sep 11, 2026 |
| FY2025 Earnings Presentation | Earnings | 19 slides | Apr 21, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 16 slides | Nov 21, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 17 slides | Nov 21, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 18 slides | May 28, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 18 slides | May 28, 2025 |
| FY2024 Earnings Presentation | Earnings | 20 slides | Apr 25, 2025 |
| FY2024 Earnings Presentation | Earnings | 20 slides | Apr 25, 2025 |
| IPO Roadshow (January 2025) | IPO roadshow | 5 slides | January 2025 |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.41B | 1.95B | 1.59B | 1.44B | 1.84B |
| Cost of revenue | 505.0M | 420.0M | 554.5M | 500.0M | 538.1M |
| Gross profit | 1.91B | 1.53B | 1.03B | 935.5M | 1.30B |
| Operating income | 383.7M | 337.3M | 233.4M | 252.0M | 687.5M |
| Depreciation and amortization | 201.8M | 161.5M | 147.2M | 125.9M | 113.8M |
| EBITDA | 585.5M | 498.8M | 380.7M | 377.9M | 801.4M |
| Interest expense | 68.9M | 57.4M | 54.2M | 32.8M | 23.3M |
| Income before tax | 316.9M | 291.2M | 173.6M | 221.8M | 699.9M |
| Net income | 251.6M | 223.3M | 123.4M | 167.4M | 557.8M |
| Earnings per share, basic | 7.45 | 6.62 | 3.66 | 4.96 | 16.52 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 18.4M | 40.5M | 94.9M | 91.0M | 164.5M |
| Receivables | 258.3M | 222.8M | 158.4M | 131.0M | 211.4M |
| Inventory | 68.7M | 45.4M | 38.7M | 35.0M | 46.7M |
| Current assets | 368.7M | 327.0M | 323.2M | 285.0M | 436.9M |
| Goodwill | 478.1M | 414.8M | 303.9M | 243.0M | 222.5M |
| Total assets | 2.07B | 1.72B | 1.40B | 1.20B | 1.26B |
| Accounts payable | 135.0M | 100.8M | 78.3M | 65.1M | 73.5M |
| Current liabilities | 506.8M | 396.0M | 313.1M | 250.0M | 361.1M |
| Long-term debt | 627.7M | 577.3M | 534.5M | 425.7M | 257.8M |
| Total liabilities | 1.52B | 1.28B | 1.06B | 878.4M | 819.3M |
| Shareholders' equity | 528.4M | 418.6M | 325.1M | 312.5M | 437.6M |
| Shares outstanding | 33.8M | 33.8M | 33.8M | 33.8M | 33.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | 551.8M | 415.4M | 336.0M | 283.9M | 738.5M |
| Capital spending | -204.8M | -132.7M | -81.3M | -89.4M | -131.6M |
| Free cash flow | 347.0M | 282.7M | 254.7M | 194.5M | 606.9M |
| Dividends paid | -111.7M | -105.7M | -112.1M | -294.3M | -413.4M |
| Change in cash | -22.1M | -56.8M | 6.29M | -73.6M | 9.36M |
Cap table
Built by 6ix from Diagnostyka S.A.’s releases
- Common shares
- 33,756,500
- Fully diluted
- 33,756,500
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 33,756,500 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 33,756,500 |
Log in to ask 6ix AI your own questions about Diagnostyka S.A.